Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0BQE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,363
Award facts
- Contract value 100% obligated
- $21,362.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $21,362.56 delivery order to AmerisourceBergen Drug Corp on April 22, 2026, for XELJANZ XR 11 MG tablets (30-count units).
Place of performance is Conshohocken, PA. The order closes April 23, 2026. Pricing is firm fixed price with no set-aside. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying medications and medical devices to federal healthcare systems and the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F0BQE?
SPE2DR26F0BQE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2026.
How much is contract SPE2DR26F0BQE worth?
The government has obligated $21,363 on SPE2DR26F0BQE.
Is contract SPE2DR26F0BQE an order under another contract?
Yes. SPE2DR26F0BQE is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0BQE competed?
The extent of competition for SPE2DR26F0BQE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award